InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Salzman Barry M, 董事. Insider active across 1 company, notably Checkpoint Therapeutics, Inc.. Cumulatively, 6 disclosures have been recorded. Activity tracked since 10 June 2021. The latest transaction was filed on 28 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Salzman Barry M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
12,195 股0COMMON STOCKSEC:0001104659-25-054695:0
17,638 股0COMMON STOCKSEC:0001104659-24-129527:0
32,051 股0COMMON STOCKSEC:0001104659-24-062665:0
17,483 股0COMMON STOCKSEC:0001104659-23-071760:0
47,619 股0COMMON STOCKSEC:0001104659-22-074465:0
16,502 股0COMMON STOCKSEC:0001104659-21-080363:0
6 条申报中的 6 条
About Salzman Barry M
Barry M. Salzman is a Board Member at Checkpoint Therapeutics, Inc. He has significant experience in corporate governance and business strategy. Barry plays a key role in guiding board decisions and implementing best practices within the company.
